Prime Focus Limited has submitted a regulatory filing to the National Stock Exchange of India Limited and BSE Limited regarding an upcoming Board of Directors meeting.
The Board meeting is scheduled for Friday, September 04, 2026. The agenda includes two key items:
1. Consideration and approval of an increase in the authorized share capital of the Company, with consequent amendment to the capital clause of the Memorandum of Association (MOA), subject to statutory/regulatory approvals as required.
2. Consideration, evaluation and approval of a proposal to raise funds through one or more permissible mechanisms deemed appropriate by the Board. The fundraising may include:
- Issuance of equity shares
- Debt securities or non-convertible securities
- Other securities including share warrants
- Any other equity linked securities
- Qualified Institutions Placement (QIP)
- Issuance of Depository Receipts (ADRs/GDRs)
- Preferential issue on a private placement basis
- Rights issue
- Any other permissible mode
- Any combinations of the above
The fundraising may be conducted in one or more tranches as decided by the Board, subject to member approvals and/or statutory/regulatory approvals as required.
The trading window for dealing in the Company's securities is currently closed pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 (as amended). The trading window will reopen after 48 hours following the declaration of the meeting outcome.
This notice is available on the company's website (www.primefocus.com) as well as on BSE (www.bseindia.com) and NSE (www.nseindia.com) websites.
The filing was made pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, and was digitally signed by Parina Shah, Company Secretary & Compliance Officer of Prime Focus Limited.
Financial Impact
Financial impact not quantified in the disclosure. Specific amounts for capital increase and fundraising will be determined by the Board and subject to subsequent approvals.